The Indian Journal of Chest Diseases and Allied Sciences

Register      Login

VOLUME 65 , ISSUE 2 ( April-June, 2023 ) > List of Articles


Treatment of Isoniazid-resistant Tuberculosis: Need to Revisit

Manohar Lal Gupta, Shyam Sunder Yadav

Keywords : Epidemiology, Monoresistance, Multidrug-resistant, Tuberculosis

Citation Information : Gupta ML, Yadav SS. Treatment of Isoniazid-resistant Tuberculosis: Need to Revisit. Indian J Chest Dis Allied Sci 2023; 65 (2):83-84.

DOI: 10.5005/jp-journals-11007-0066

License: CC BY-NC 4.0

Published Online: 01-11-2023

Copyright Statement:  Copyright © 2023; The Author(s).


PDF Share
  1. Global Tuberculosis Programme. WHO operational handbook on tuberculosis: Module 4: Treatment: Drug-susceptible tuberculosis treatment. Available from:
  2. Global Tuberculosis Programme. WHO operational handbook on tuberculosis. Module 4: Treatment - Drug-resistant tuberculosis treatment, 2022 update. Available from:
  3. Ministry of Health and Family Welfare Government of India. Report of the first national anti-tuberculosis drug resistance survey: India 2014–16, 2018;1–24. Available from:
  4. American Thoracic Society. Medical section of the American lung association: Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis 1986;134(2):355–363. DOI: 10.1164/arrd.1986.134.2.355.
  5. Fox W. Whither short-course chemotherapy? Br J Dis Chest 1981;75(4):331–357. DOI: 10.1016/0007-0971(81)90022-x.
  6. Kumar P, Balooni V, Sharma BK, et al. High degree of multi-drug resistance and hetero-resistance in pulmonary TB patients from Punjab state of India. Tuberculosis (Edinb) 2014;94(1):73–80. DOI: 10.1016/
  7. Stagg HR, Bothamley GH, Davidson JA, et al. Fluoroquinolones and isoniazid-resistant tuberculosis: Implications for the 2018 WHO guidance. Eur Respir J 2019;54(4):1900982. DOI: 10.1183/13993003.00982-2019.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.